Literature DB >> 10503893

Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods.

Y Totsuka1, H Ushiyama, J Ishihara, R Sinha, S Goto, T Sugimura, K Wakabayashi.   

Abstract

Co-mutagenic beta-carbolines, such as norharman and harman, were quantified in mainstream and sidestream smoke condensates of six Japanese brands of cigarettes, and also in 13 kinds of cooked foods, using a combination of blue cotton treatment and HPLC. Norharman and harman were detected in all the cigarette smoke condensate samples. Their levels in the mainstream smoke case were 900-4240 ng per cigarette for norharman, and 360-2240 ng for harman, and in sidestream smoke, 4130-8990 ng for norharman and 2100-3000 ng for harman. These beta-carbolines were also found to be present in all the cooked food samples, at levels of 2.39-795 ng for norharman and 0.62-377 ng for harman per gram of cooked food. The observed concentrations are much higher than those found for mutagenic and carcinogenic heterocyclic amines (HCAs), suggesting that humans are exposed to norharman and harman in daily life to a larger extent than to HCAs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503893     DOI: 10.1016/s0304-3835(99)00143-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  Detection of bioactive exometabolites produced by the filamentous marine cyanobacterium Geitlerinema sp.

Authors:  Nelson H Caicedo; Jolanta Kumirska; Jennifer Neumann; Stefan Stolte; Jorg Thöming
Journal:  Mar Biotechnol (NY)       Date:  2011-12-13       Impact factor: 3.619

Review 2.  Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.

Authors:  Kelly P Cosgrove; Irina Esterlis; Graeme F Mason; Frederic Bois; Stephanie S O'Malley; John H Krystal
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

Review 3.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

4.  Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.

Authors:  David J Wagner; Haichuan Duan; Alenka Chapron; Richard W Lee; Joanne Wang
Journal:  Xenobiotica       Date:  2017-03-02       Impact factor: 1.908

Review 5.  Dietary inhibitors of monoamine oxidase A.

Authors:  Sarah E Dixon Clarke; Rona R Ramsay
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 6.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

7.  Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.

Authors:  A Ostergren; A Fredriksson; E B Brittebo
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

8.  Tobacco smoke exposure induces nicotine dependence in rats.

Authors:  Elysia Small; Hina P Shah; Jake J Davenport; Jacqueline E Geier; Kate R Yavarovich; Hidetaka Yamada; Sreedharan N Sabarinath; Hartmut Derendorf; James R Pauly; Mark S Gold; Adrie W Bruijnzeel
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

9.  Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness.

Authors:  Elan D Louis; Wei Zheng; Wendy Jiang; Kenneth T Bogen; Garrett A Keating
Journal:  J Toxicol Environ Health A       Date:  2007-06

10.  Cancer and blood concentrations of the comutagen harmane in essential tremor.

Authors:  Elan D Louis; Kathryn M Pellegrino; Pam Factor-Litvak; Eileen Rios; Wendy Jiang; Claire Henchcliffe; Wei Zheng
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.